LUNG
Price
$7.11
Change
-$0.01 (-0.14%)
Updated
Nov 5 closing price
105 days until earnings call
XVIPF
Price
$42.00
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
Ad is loading...

LUNG vs XVIPF

Header iconLUNG vs XVIPF Comparison
Open Charts LUNG vs XVIPFBanner chart's image
Pulmonx
Price$7.11
Change-$0.01 (-0.14%)
Volume$262.6K
CapitalizationN/A
Xvivo Perfusion AB
Price$42.00
Change-$0.00 (-0.00%)
Volume$200
CapitalizationN/A
View a ticker or compare two or three
LUNG vs XVIPF Comparison Chart
Loading...
LUNG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
LUNG vs. XVIPF commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LUNG is a StrongBuy and XVIPF is a Hold.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (LUNG: $7.11 vs. XVIPF: $42.00)
Brand notoriety: LUNG and XVIPF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LUNG: 104% vs. XVIPF: 177%
Market capitalization -- LUNG: $357.24M vs. XVIPF: $905.23M
LUNG [@Medical Specialties] is valued at $357.24M. XVIPF’s [@Medical Specialties] market capitalization is $905.23M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LUNG’s FA Score shows that 0 FA rating(s) are green whileXVIPF’s FA Score has 0 green FA rating(s).

  • LUNG’s FA Score: 0 green, 5 red.
  • XVIPF’s FA Score: 0 green, 5 red.
According to our system of comparison, XVIPF is a better buy in the long-term than LUNG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LUNG’s TA Score shows that 5 TA indicator(s) are bullish.

  • LUNG’s TA Score: 5 bullish, 5 bearish.

Price Growth

LUNG (@Medical Specialties) experienced а +5.02% price change this week, while XVIPF (@Medical Specialties) price change was -2.80% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.64%. For the same industry, the average monthly price growth was -0.19%, and the average quarterly price growth was -1.08%.

Reported Earning Dates

LUNG is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Medical Specialties (+0.64% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XVIPF($905M) has a higher market cap than LUNG($357M). XVIPF YTD gains are higher at: 84.211 vs. LUNG (-44.235). XVIPF has higher annual earnings (EBITDA): 29.2M vs. LUNG (-55.49M). XVIPF has more cash in the bank: 171M vs. LUNG (117M). XVIPF has less debt than LUNG: XVIPF (27.6M) vs LUNG (41.4M). XVIPF has higher revenues than LUNG: XVIPF (524M) vs LUNG (68.7M).
LUNGXVIPFLUNG / XVIPF
Capitalization357M905M39%
EBITDA-55.49M29.2M-190%
Gain YTD-44.23584.211-53%
P/E RatioN/A344.83-
Revenue68.7M524M13%
Total Cash117M171M68%
Total Debt41.4M27.6M150%
FUNDAMENTALS RATINGS
XVIPF: Fundamental Ratings
XVIPF
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
48
SMR RATING
1..100
68
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LUNG
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 13 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
LUNG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSDMX13.690.05
+0.37%
Morgan Stanley Emerging Mkt ex China R6
FGIWX12.160.01
+0.08%
Nuveen Global Infrastructure R6
JHIGX27.17N/A
N/A
JHancock International Growth R2
PGIUX14.89N/A
N/A
Virtus Duff & Phelps Global Infras I
ABCAX23.55-0.09
-0.38%
American Beacon The London Co Inc Eq A

LUNG and

Correlation & Price change

A.I.dvisor indicates that over the last year, LUNG has been loosely correlated with SRTS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if LUNG jumps, then SRTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUNG
1D Price
Change %
LUNG100%
-0.14%
SRTS - LUNG
57%
Loosely correlated
+2.99%
QTRX - LUNG
49%
Loosely correlated
+4.84%
KIDS - LUNG
44%
Loosely correlated
+3.72%
VAPO - LUNG
42%
Loosely correlated
N/A
IRMD - LUNG
41%
Loosely correlated
+6.85%
More

XVIPF and

Correlation & Price change

A.I.dvisor tells us that XVIPF and USAQ have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XVIPF and USAQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XVIPF
1D Price
Change %
XVIPF100%
N/A
USAQ - XVIPF
22%
Poorly correlated
N/A
NSTM - XVIPF
21%
Poorly correlated
+19.80%
VYCO - XVIPF
17%
Poorly correlated
N/A
ZTEK - XVIPF
9%
Poorly correlated
+16.16%
LUNG - XVIPF
6%
Poorly correlated
+13.56%
More